Loading…
Lobbying Spend
—
Filings
63
Firms Hired
1
Active Period
2012–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Combating Organized Retail Crime Act of 2025
2026 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA) and S. 3376, The Cargo Security Innovation Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 2853
Cargo Security Innovation Act
2026 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA) and S. 3376, The Cargo Security Innovation Act.
Client expense: — · Firm income: $40,000
Matched citations: S. 3376
Combating Organized Retail Crime Act of 2025
2026 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA) and S. 3376, The Cargo Security Innovation Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 2853
Cargo Security Innovation Act
2026 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA) and S. 3376, The Cargo Security Innovation Act.
Client expense: — · Firm income: $40,000
Matched citations: S. 3376
Combating Organized Retail Crime Act of 2025
2026 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2853
Combating Organized Retail Crime Act of 2025
2025 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2853
Combating Organized Retail Crime Act of 2025
2025 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 2853
DXM Abuse Prevention Act of 2015
2016 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the global health care supply chain including the implementation of unique device identifiers requirements, and the Drug Supply Chain Security Act. Issues related to the sale of medicines that contain dextromethorphan, including H. R. 3250 the DXM Abuse Prevention Act.
Client expense: — · Firm income: $50,000
Matched citations: H. R. 3250
Improving Health Information Technology Act
2016 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the global health care supply chain including the implementation of unique device identifiers requirements, and the Drug Supply Chain Security Act. S.2511, the Improving Health Information Technology Act as it relates to health care information technology standards.
Client expense: — · Firm income: $50,000
Matched citations: S.2511
Drug Quality and Security Act
2014 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues relating to track and trace and compounding included in H.R.3204 and S.959, the Drug Quality and Security Act and the implementation of unique device identifier requirements.
Client expense: — · Firm income: $50,000
Matched citations: H.R.3204
Pharmaceutical Quality, Security, and Accountability Act
2014 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues relating to track and trace and compounding included in H.R.3204 and S.959, the Drug Quality and Security Act and the implementation of unique device identifier requirements.
Client expense: — · Firm income: $50,000
Matched citations: S.959
Drug Quality and Security Act
2013 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues relating to track and trace and compounding included in H.R.3204 and S.959, the Drug Quality and Security Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.3204
Pharmaceutical Quality, Security, and Accountability Act
2013 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues relating to track and trace and compounding included in H.R.3204 and S.959, the Drug Quality and Security Act.
Client expense: — · Firm income: $50,000
Matched citations: S.959
Safeguarding America's Pharmaceuticals Act of 2013
2013 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues relating to implementation of a unique device identifier and proposals related to drug supply chain integrity including H.R.1919 and S.957; H.R. 3204, Drug Quality and Security Act; regulation relating to the Unique Device Identifier.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1919
Drug Quality and Security Act
2013 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues relating to implementation of a unique device identifier and proposals related to drug supply chain integrity including H.R.1919 and S.957; H.R. 3204, Drug Quality and Security Act; regulation relating to the Unique Device Identifier.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3204
Drug Supply Chain Security Act
2013 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues relating to implementation of a unique device identifier and proposals related to drug supply chain integrity including H.R.1919 and S.957; H.R. 3204, Drug Quality and Security Act; regulation relating to the Unique Device Identifier.
Client expense: — · Firm income: $50,000
Matched citations: S.957
Safeguarding America's Pharmaceuticals Act of 2013
2013 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues relating to implementation of a unique device identifier and proposals related to drug supply chain integrity including H.R.1919 and S.957.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1919
Drug Supply Chain Security Act
2013 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues relating to implementation of a unique device identifier and proposals related to drug supply chain integrity including H.R.1919 and S.957.
Client expense: — · Firm income: $50,000
Matched citations: S.957
Source: Senate LDA